MedTrace Logo

Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn

NCT01499238 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-12-26

No results posted yet for this study

Summary

The investigators aimed to compare the efficacy of nasal SIMV and nasal CPAP in patients with wet lung.

Conditions

  • Transient Tachypnea of Newborn

Interventions

DEVICE

Nasal SIMV

rate: 30-50/min, PIP: 16-20, PEEP: 4-6, FİO2: 40%

DEVICE

nasal CPAP

PEEP: 4-6 mmHg, FİO2: 40%

Sponsors & Collaborators

  • Zekai Tahir Burak Women's Health Research and Education Hospital

    lead OTHER

Principal Investigators

  • Gamze Demirel, MD · Zekai Tahir Burak Women's Health Research and Education Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
2 Hours
Max Age
3 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-02-29
Completion
2012-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01499238 on ClinicalTrials.gov